RAPT Therapeutics Slips 9% After Pricing Public Offering

On:

Shares of RAPT Therapeutics, Inc. (RAPT) are down more than 9% Friday morning at $19.26.

The company today priced its public offering of 4,054,055 shares at $18.50 per share.

Gross proceeds of $75 million is estimated from the offering, which is expected to close on November 22.

RAPT has traded in the range of $9.85- $40.74 in the last 1 year.

Source: Read Full Article

Lates News:
  1. Bitcoin Enthusiast Implants NFC Chip In His Hand to Make BTC Lightning Payments
  2. AngloGold Ashanti Adds 6% On Decision To Invest $$$ In G2 Goldfields
  3. ‪"Market Manipulation?" — Former SEC Official Reveals Factors Propelling Bitcoin’s Latest Price Ascent
  4. Cryptos Subdued Ahead Of Earnings Updates From Wall Street’s Tech Space
  5. Vericel Rises 12%; Prel. Annual Revenue In Line With Estimates